Study Type
Interventional - Drug
To determine the feasibility of a controlled trial examining the efficacy and safety of novel oral anticoagulants (NOACs), compared with aspirin, for stroke prevention in patients with high-risk atrial fibrillation (AF) and previous intracerebral hemorrhage (ICH).
The primary outcome is composite of ischemic stroke and recurrent ICH.
Interventional - Drug
Open-label, multicentre phase II randomized pilot study
1
9
30
2017-2019
PHRI
Back To Top